Reply
Mon 2 Apr, 2007 09:57 am
Technique to convert blood types could end shortages
By John von Radowitz
Published: 02 April 2007
Scientists have developed a simple method of converting blood from one group to another.
The breakthrough could potentially mean the end of blood shortages by boosting much-needed supplies of group O negative blood. That blood type is known as "universal" because it can be given to anyone. Giving patients the wrong blood type can result in death.
Writing in the journal Nature Biotechnology, an international team of researchers described how they converted blood from group A, B or AB to group O. The process uses bacterial enzymes as biological "scissors" to cut sugar molecules from the surface of red blood cells.
People in groups A and B have blood containing one of two different sugar molecules which can trigger an immune response. Those in group O have neither of these "antigens", while those in group AB have both.
The scientists, led by Professor Henrik Clausen, from the University of Copenhagen in Denmark, started by screening 2,500 types of fungi and bacteria looking for useful proteins.
Two bacteriums, Elizabethkingia meningosepticum, and Bacteroides fragilis, yielded enzymes capable of removing both A and B antigens from red blood cells.
That was verified by standard laboratory tests. After an hour's exposure to the appropriate enzyme, the antigens vanished from 200 millilitre samples of A, B and AB blood.
The researchers wrote: "Clinical translation of this approach may allow improvement of the blood supply and enhancement of patient safety in transfusion medicine."
Patient trials will have to take place before group O blood produced by the conversion method can be used in hospitals.
Re: Technique to convert blood types could end shortages
BumbleBeeBoogie wrote:Patient trials will have to take place before group O blood produced by the conversion method can be used in hospitals.
Since death results in a very short time (minutes) from the transfusion of ABO incompatible blood, I think it will be hard to get informed consent from many individuals for human trials. Somehow, I see the military (where blood supplies are lowest and the need often greatest) as the logical first guinea pigs for this experiment.
I was wondering about your take on it, JPB; that makes sense.
Well, it's probably a looooong ways from human trials. Artificial blood has been touted as the logical supplement for type-nonspecific blood for over a decade and hasn't gotten any further than these folks. I wouldn't hold my breath, but anything is possible.
Many of the advancements in transfusion technology and applications are the result of supplying the military during times of war - this would fit in the same realm.